Heart failure & cardiomyopathies

Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial

Circ Heart FailPublished post hoc analysis of the CLOROTIC trial

Authors' conclusion

Adding HCTZ to intravenous furosemide increases the risk of hypokalemia a especially when baseline K + is ≤4.3 mmol/L and when patients are not treated with a mineralocorticoid receptor antagonist. In patients treated with furosemide and HCTZ, it is advisable to add potassium supplements or a mineralocorticoid receptor antagonist.

Study context

Population
Patients with acute heart failure and volume overload receiving intravenous furosemiderandomized
Participants
230 patients
Comparison
Hydrochlorothiazide (HCTZ) or placebo in addition to intravenous furosemide
Methodological detailsrandomized, Monte Carlo simulation
  • Randomized
  • Monte Carlo simulation

Primary result

As reported in the abstract

Incidence of hypokalemia (K + <3.5 mmol/L) · 48 and 96 hours after randomization, and at discharge
  • HCTZ vs placebo: P < 0.001

Further findings

Independent associations with development of hypokalemia (multivariate analysis)

ComparisonEstimateP value
Baseline K + valuesOR per 0.1 units 0.82 (95% CI 0.76–0.87)P < 0.001
Treatment with HCTZOR 4.90 (95% CI 2.50–9.90)P < 0.001
Treatment with a mineralocorticoid receptor antagonist at baselineOR 0.42 (95% CI 0.20–0.84)P = 0.017

30- and 90-day mortality and readmissions · 30 and 90 days

No association between the development of hypokalemia and 30- and 90-day mortality and readmissions

Monte Carlo simulation of hypokalemia risk

Furosemide alone: higher risk of hypokalemia when baseline K + values are
≤3.7 mmol/L
HCTZ added to furosemide: risk of hypokalemia present with baseline K + values
≤4.3 mmol/L

Original publication

Hypokalemia During Decongestion With Loop Diuretics and Hydrochlorothiazide, a Post Hoc Analysis of the CLOROTIC Trial. Circ Heart Fail. Published 1 July 2025. doi:10.1161/circheartfailure.125.012914

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.